A six-gene signature predicting breast cancer lung metastasis

…, E Ricevuto, C Nogues, M Briffod, I Bieche, P Cherel… - Cancer research, 2008 - AACR
The lungs are a frequent target of metastatic breast cancer cells, but the underlying
molecular mechanisms are unclear. All existing data were obtained either using statistical …

Preoperative breast magnetic resonance imaging in women with local ductal carcinoma in situ to optimize surgical outcomes: results from the randomized phase III …

…, M Kandel, MP Chauvet, P Chérel… - Journal of Clinical …, 2019 - ascopubs.org
PURPOSE We evaluated the addition of breast magnetic resonance imaging (MRI) to standard
radiologic evaluation on the re-intervention rate in women with ductal carcinoma in situ (…

[HTML][HTML] Brain metastases from breast cancer: prognostic significance of HER-2 overexpression, effect of trastuzumab and cause of death

…, C Massard, M Gutierrez, Y Kirova, P Cherel… - BMC cancer, 2011 - Springer
Background To access the prognostic significance of HER-2 overexpression, the effect of
trastuzumab and the cause of death in patients with brain metastases (BM) from breast cancer (…

Impact of FDG PET-CT imaging on the decision making in the biologic suspicion of ovarian carcinoma recurrence

M Soussan, M Wartski, P Cherel, E Fourme… - Gynecologic …, 2008 - Elsevier
OBJECTIVES.: The aim of this prospective study was to evaluate the impact of integrated
PET-CT on treatment management in ovarian carcinoma recurrence suspicion because of …

Rates of upgrade to malignancy for 271 cases of flat epithelial atypia (FEA) diagnosed by breast core biopsy

…, A Boudinet, JM Guinebretiere, P Cherel - Breast cancer research …, 2012 - Springer
Flat epithelial atypia (FEA) is a borderline lesion that might represent an early stage in the
development of certain low-grade carcinomas in situ and invasive cancers. There are no …

Randomized phase 2 neoadjuvant trial evaluating anastrozole and fulvestrant efficacy for postmenopausal, estrogen receptor–positive, human epidermal growth …

…, R Salmon, V Becette, C Bourgier, P Cherel… - Cancer, 2016 - Wiley Online Library
BACKGROUND Treatment strategies for locally advanced breast cancer in elderly patients
too frail to receive neoadjuvant chemotherapy and the introduction of new classes of drugs in …

Underestimation rate at MR imaging–guided vacuum-assisted breast biopsy: a multi-institutional retrospective study of 1509 breast biopsies

C Verheyden, E Pages-Bouic, C Balleyguier, P Cherel… - Radiology, 2016 - pubs.rsna.org
Purpose To assess the rate of underestimation of atypical ductal hyperplasia (ADH) and
ductal carcinoma in situ (DCIS) at magnetic resonance (MR) imaging–guided vacuum-assisted …

Laryngeal schwannomas.

…, E Mahé, A Banal, A Gentile, P Cherel… - European journal of …, 1995 - europepmc.org
As laryngeal schwannomas are a threat to breathing, they must be removed. CT and MR
provide an accurate pre-operative work-up of these lesions. The clear delineation of the tumoral …

18F-FDG PET/CT imaging versus dynamic contrast-enhanced CT for staging and prognosis of inflammatory breast cancer

L Champion, F Lerebours, P Cherel, V Edeline… - European journal of …, 2013 - Springer
Purpose Inflammatory breast cancer (IBC) is the most aggressive type of breast cancer with
a poor prognosis. Locoregional staging is based on dynamic contrast-enhanced (DCE) CT …

[HTML][HTML] Quantitative CT extent of lung damage in COVID-19 pneumonia is an independent risk factor for inpatient mortality in a population of cancer patients: a …

…, P Moreau, A Noret, P Vuagnat, P Cherel… - Frontiers in …, 2020 - frontiersin.org
Background: CT lung extent has emerged as a potential risk factor of COVID-19 pneumonia
severity with mainly semiquantitative assessment, and outcome was not assessed in the …